These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 21540026)
1. cDNA microarray analysis and immunohistochemistry reveal a distinct molecular phenotype in serous endometrial cancer compared to endometrioid endometrial cancer. Chen Y; Yao Y; Zhang L; Li X; Wang Y; Zhao L; Wang J; Wang G; Shen D; Wei L; Zhao J Exp Mol Pathol; 2011 Aug; 91(1):373-84. PubMed ID: 21540026 [TBL] [Abstract][Full Text] [Related]
2. Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer. Maxwell GL; Chandramouli GV; Dainty L; Litzi TJ; Berchuck A; Barrett JC; Risinger JI Clin Cancer Res; 2005 Jun; 11(11):4056-66. PubMed ID: 15930340 [TBL] [Abstract][Full Text] [Related]
3. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Zorn KK; Bonome T; Gangi L; Chandramouli GV; Awtrey CS; Gardner GJ; Barrett JC; Boyd J; Birrer MJ Clin Cancer Res; 2005 Sep; 11(18):6422-30. PubMed ID: 16166416 [TBL] [Abstract][Full Text] [Related]
4. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases. Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034 [TBL] [Abstract][Full Text] [Related]
5. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers. Xiong Y; Dowdy SC; Xue A; Shujuan J; Eberhardt NL; Podratz KC; Jiang SW Gynecol Oncol; 2005 Mar; 96(3):601-9. PubMed ID: 15721400 [TBL] [Abstract][Full Text] [Related]
6. Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma. Sobel G; Németh J; Kiss A; Lotz G; Szabó I; Udvarhelyi N; Schaff Z; Páska C Gynecol Oncol; 2006 Nov; 103(2):591-8. PubMed ID: 16797678 [TBL] [Abstract][Full Text] [Related]
7. [Study of differential gene expression in different stage human endometrial cancer]. Wan XP; Cai B; Liu L; Xi XW; Yang YX Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):38-42. PubMed ID: 16635327 [TBL] [Abstract][Full Text] [Related]
8. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer. Santin AD; Diamandis EP; Bellone S; Soosaipillai A; Cane S; Palmieri M; Burnett A; Roman JJ; Pecorelli S Clin Cancer Res; 2005 May; 11(9):3320-5. PubMed ID: 15867230 [TBL] [Abstract][Full Text] [Related]
9. Methylation profiles of endometrioid and serous endometrial cancers. Seeber LM; Zweemer RP; Marchionni L; Massuger LF; Smit VT; van Baal WM; Verheijen RH; van Diest PJ Endocr Relat Cancer; 2010 Sep; 17(3):663-73. PubMed ID: 20488783 [TBL] [Abstract][Full Text] [Related]
10. Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas. Moreno-Bueno G; Sánchez-Estévez C; Cassia R; Rodríguez-Perales S; Díaz-Uriarte R; Domínguez O; Hardisson D; Andujar M; Prat J; Matias-Guiu X; Cigudosa JC; Palacios J Cancer Res; 2003 Sep; 63(18):5697-702. PubMed ID: 14522886 [TBL] [Abstract][Full Text] [Related]
11. IMP2 expression distinguishes endometrioid from serous endometrial adenocarcinomas. Zhang L; Liu Y; Hao S; Woda BA; Lu D Am J Surg Pathol; 2011 Jun; 35(6):868-72. PubMed ID: 21566514 [TBL] [Abstract][Full Text] [Related]
12. Expression profile of mammalian microRNAs in endometrioid adenocarcinoma. Wu W; Lin Z; Zhuang Z; Liang X Eur J Cancer Prev; 2009 Feb; 18(1):50-5. PubMed ID: 19077565 [TBL] [Abstract][Full Text] [Related]
13. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910 [TBL] [Abstract][Full Text] [Related]
14. Use of gene expression profiles to stage concurrent endometrioid tumors of the endometrium and ovary. Guirguis A; Elishaev E; Oh SH; Tseng GC; Zorn K; DeLoia JA Gynecol Oncol; 2008 Feb; 108(2):370-6. PubMed ID: 18083218 [TBL] [Abstract][Full Text] [Related]
16. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses. Lax SF; Kurman RJ Verh Dtsch Ges Pathol; 1997; 81():228-32. PubMed ID: 9474874 [TBL] [Abstract][Full Text] [Related]
17. Distinctive gene expression profiles by cDNA microarrays in endometrioid and serous carcinomas of the endometrium. Cao QJ; Belbin T; Socci N; Balan R; Prystowsky MB; Childs G; Jones JG Int J Gynecol Pathol; 2004 Oct; 23(4):321-9. PubMed ID: 15381901 [TBL] [Abstract][Full Text] [Related]
18. Serous versus high-grade endometrioid endometrial carcinoma: immunohistochemistry of RFP is not useful for differentiation. Ussakli C; Usubutun A; Dincer N; Dolgun A; Bülbül D; Isikdogan Z; Haberal N; Ozen O; Tezel GG Pol J Pathol; 2016; 67(3):221-227. PubMed ID: 28155970 [TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators. An HJ; Kim KI; Kim JY; Shim JY; Kang H; Kim TH; Kim JK; Jeong JK; Lee SY; Kim SJ Am J Surg Pathol; 2007 Jun; 31(6):846-53. PubMed ID: 17527071 [TBL] [Abstract][Full Text] [Related]
20. Strategies for distinguishing low-grade endometrioid and serous carcinomas of endometrium. Garg K; Soslow RA Adv Anat Pathol; 2012 Jan; 19(1):1-10. PubMed ID: 22156830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]